LexDanaLexDanabeta
Inventor

Peter D. Williams

Inventor
Harleysville, PA, US

Overview

35→
Patents
1991–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 35 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds42%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes18%
C07KPeptides8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07CAcyclic or carbocyclic compounds3%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
10,696,639Heterocyclic compounds as HIV protease inhibitors202010,138,255Piperazine derivatives as HIV protease inhibitors20189,994,587HIV protease inhibitors20189,840,478'Piperazine derivatives as HIV protease inhibitors'20179,834,526HIV protease inhibitors20179,737,545'HIV protease inhibitors'20179,550,786'4-fluoropiperidine orexin receptor antagonists'20179,315,475'HIV protease inhibitors'20168,871,796'Diaryl ether derivatives as notch sparing gamma secretase inhibitors'20148,513,234'HIV integrase inhibitors'20137,820,680'HIV integrase inhibitors'20107,619,086'HIV integrase inhibitors'20097,517,532'Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors'20097,476,666'HIV integrase inhibitors'20097,144,899'Thrombin inhibitors'20067,026,324'Thrombin inhibitors'20066,528,503'Thrombin inhibitors'20036,515,011'Thrombin inhibitors'20036,455,532'Pyrazinone thrombin inhibitors'20026,090,805'Tocolytic oxytocin receptor antagonists'20006,087,373'Thrombin inhibitors'20005,968,938'Piperazine oxytocin receptor antagonists'19995,756,497'Tocolytic oxytocin receptor antagonists'19985,756,504'Tocolytic oxytocin receptor antagonists'19985,726,172'Tocolytic oxytocin receptor antagonists'19985,693,643'Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists'19975,670,509'Tocolytic oxytocin receptor antagonists'19975,665,719'Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists'19975,648,352'Piperazinylcamphorsulfonyl oxytocin antagonists'19975,492,917'Endothelin antagonists incorporating a cyclobutane'19965,464,788'Tocolytic oxytocin receptor antagonists'19955,356,904'Carbostyril oxytocin receptor antagonists'19945,225,528'Cyclic hexapeptide oxytocin antagonists'19935,006,511'Di- or tripeptide renin inhibitors containing lactam conformational restriction in achpa'19915,001,113'Di- or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA'1991

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1991–2010Patents assigned to MERCK & CO INC (25)· patent assignee history
1991Based in Lansdale, PA, US· patent location history
1993–2020Based in Harleysville, PA, US· patent location history
2013–2020Patents assigned to MERCK SHARP & DOHME (10)· patent assignee history
2013–2016Patents assigned to WILLIAMS PETER D (3)· patent assignee history
2014–2016Patents assigned to WISCOUNT CATHERINE M (2)· patent assignee history
2016–2018Patents assigned to MERCK CANADA INC (4)· patent assignee history
2017Based in Rahway, NJ, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK & CO INC251991–2010
MERCK SHARP & DOHME102013–2020
MERCK CANADA INC42016–2018
WILLIAMS PETER Dself32013–2016
WISCOUNT CATHERINE M22014–2016
Locations
LocationPatentsSpan
Harleysville, Pennsylvania, US321993–2020
Lansdale, Pennsylvania, US21991
Rahway, New Jersey, US12017